X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MOLECULAR NEUROBIOLOGY

期刊標題檢索 MOL NEUROBIOL 最新評論: The technical issues were returned twice, and the manuscript was rejec... (2024-11-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MOLECULAR NEUROBIOLOGY]您好,您是該頁面的第 129333 位訪客。

期刊簡介
期刊名稱MOLECULAR NEUROBIOLOGY MOLECULAR NEUROBIOLOGY
LetPub Score
7.9
50 ratings
Rate

Reputation
8.7

Influence
7.0

Speed
7.5

期刊簡稱MOL NEUROBIOL
ISSN0893-7648
E-ISSN1559-1182
h-index96
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.001.3390.976
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Neurology
Q127 / 192
Category: Neuroscience
Subcategory: Cellular and Molecular Neuroscience
Q121 / 97

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Molecular Neurobiology is an exciting journal for neuroscientists needing to stay in close touch with progress at the forefront of molecular brain research today. It is an especially important periodical for graduate students and "postdocs," specifically designed to synthesize and critically assess research trends for all neuroscientists hoping to stay active at the cutting edge of this dramatically developing area. This journal has proven to be crucial in departmental libraries, serving as essential reading for every committed neuroscientist who is striving to keep abreast of all rapid developments in a forefront field. Most recent significant advances in experimental and clinical neuroscience have been occurring at the molecular level. Until now, there has been no journal devoted to looking closely at this fragmented literature in a critical, coherent fashion. Each submission is thoroughly analyzed by scientists and clinicians internationally renowned for their special competence in the areas treated.
官方網站https://www.springer.com/12035
在線稿件提交https://www.editorialmanager.com/moln
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1987
每年文章數668每年文章數趨勢
黃金OA百分比23.13%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ166/310
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0893-7648%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【MOLECULAR NEUROBIOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS NEUROSCIENCEH-index: 357

    CiteScore: 35.00
    NATURE NEUROSCIENCEH-index: 375

    CiteScore: 38.60
    Molecular NeurodegenerationH-index: 66

    CiteScore: 23.00
    NeuronH-index: 430

    CiteScore: 24.50
    TRENDS IN NEUROSCIENCESH-index: 269

    CiteScore: 26.50
    Annual Review of NeuroscienceH-index: 224

    CiteScore: 25.30
    Journal of NeuroinflammationH-index: 92

    CiteScore: 15.90
    PROGRESS IN NEUROBIOLOGYH-index: 212

    CiteScore: 12.80
    NeurotherapeuticsH-index: 100

    CiteScore: 11.00
    GLIAH-index: 148

    CiteScore: 13.10
    學科內最受檢索的期刊 頁面查看次數
    Journal of Neuroinflammation196861
    NEUROSCIENCE189946
    JOURNAL OF NEUROSCIENCE185806
    BRAIN RESEARCH140176
    Neuron121663
    NEUROSCIENCE LETTERS115229
    CNS Neuroscience & Therapeutics110054
    NATURE NEUROSCIENCE98385
    CEREBRAL CORTEX98065
    NEUROPHARMACOLOGY94482
  •  

    MOLECULAR NEUROBIOLOGY MOLECULAR NEUROBIOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/12)
  [MOLECULAR NEUROBIOLOGY] 的評論撰寫評論
作者: 小鱼天上飞


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-11-20 20:33:21 評論於
The technical issues were returned twice, and the manuscript was rejected by the editor after one month.
(0) 讚! | 小鱼天上飞

作者: 不骄不躁陈警官


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-06 08:37:03 評論於
I have also been under review for 7 months.
(0) 讚! | 不骄不躁陈警官

作者: 中医大大混子


領域: 医学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-25 11:42:36 評論於
Original: 楼主,你接收后,好久 proof 和 on line 的
Translation: OP, after you receive it, please proofread and put it online as soon as possible.
(0) 讚! | 中医大大混子

作者: 中医大大混子


領域: 医学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-25 11:41:28 評論於
Hello, OP, received, long time no proof and online.
(0) 讚! | 中医大大混子

作者: 中医大大混子


領域: 医学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-25 11:40:22 評論於
After receiving it, probably a while on line.
(0) 讚! | 中医大大混子

作者: 中医大大混子


領域: 医学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-25 11:39:32 評論於
After receiving, probably a while online.
(0) 讚! | 中医大大混子

作者: 不骄不躁陈警官


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 08:38:18 評論於
Under review for six months, I followed up and received a response stating that it is currently under review.
(0) 讚! | 不骄不躁陈警官

作者: Martin3


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-17 09:57:18 評論於
Submitted in early May, revised in early July, minor revisions in September, accepted in early October.
(0) 讚! | Martin3

作者: Grace Parker


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 12:02:52 評論於
Could I ask everyone, how many reviewers usually need to reply after they have read the manuscript? I saw that my editor invited over ten reviewers to evaluate my paper, but none of them accepted the invitation!
(0) 讚! | Grace Parker

作者: assist


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-10 09:58:45 評論於
My editor also missed one reviewer's opinion, so we had to go back and forth a few times before the reviewer's comments were sent to us via email.
(0) 讚! | assist

作者: 司格鲁肽


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-26 20:29:36 評論於
Still no news. I have sent an email to urge, and the editor replied saying they are waiting for the invited reviewers.
(0) 讚! | 司格鲁肽

作者: 蓬莱山笑翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 16:50:06 評論於
Sorry to bother you, teacher. May I ask if you are the only reviewer until the end, or do we need to wait for the second reviewer later? I am also a reviewer now and feeling a bit anxious. Thank you.
(0) 讚! | 蓬莱山笑翠

作者: 医路顺丰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-23 16:36:04 評論於
Is it normal that it has been almost two months since I have been the first reviewer invited? Can anyone provide some guidance on this?
(0) 讚! | 医路顺丰

作者: 一斤章鱼小丸子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 08:32:49 評論於
Senior, I have been unable to find a second reviewer for my paper for three months now. There has only been one reviewer so far. Should I withdraw my submission?
(0) 讚! | 一斤章鱼小丸子

作者: Martin3


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 12:35:56 評論於
Could you please clarify if the proofreading is required for the journal on 2024.04.25, and if it should be done by the journal's proofreading agency or if we can find an agency ourselves? Thank you.
(0) 讚! | Martin3

作者: 医路顺丰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-10 16:56:19 評論於
How are you doing now, classmate?
(0) 讚! | 医路顺丰

作者: 風見瑛瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-05 09:54:05 評論於
Review speed: 6.0 | Submission hit rate: 50.0
Focused research direction: cognitive impairment
Experience sharing: Submitted in April, received first round of comments in June, and received acceptance email on August 30th.
(0) 讚! | 風見瑛瑶

作者: 筑阳蕙兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-04 15:58:50 評論於
It's too painful, I don't know how to take it back. If you want to reject it, just do it decisively.
(0) 讚! | 筑阳蕙兰

作者: 筑阳蕙兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-04 09:35:33 評論於
Update on 24.09.05, still under technical review. The technical review was reverted back on 8.28. No progress on 9.05.
(0) 讚! | 筑阳蕙兰

作者: 司格鲁肽


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 15:17:17 評論於
The manuscript submitted in mid-June is currently showing as "First reviewer(s) invited." Does this mean that there is currently one reviewer reviewing the manuscript? I don't know how long it will take, it's too slow.
(0) 讚! | 司格鲁肽

作者: 是你的修为呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 10:28:21 評論於
The same, hahaha.
(0) 讚! | 是你的修为呀

作者: 筑阳蕙兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-27 09:13:35 評論於
The update is still in the technical review stage as of 8.28. Today, the email will be sent to the editorial department, and if it's rejected, let's be direct about it. Let's not waste each other's time.
(0) 讚! | 筑阳蕙兰

作者: 筑阳蕙兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 17:08:02 評論於
In the middle, on 24.8.20, received technical checks requiring modification, and still running technical checks on 8.22.
(0) 讚! | 筑阳蕙兰

作者: 筑阳蕙兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 21:31:26 評論於
Research focus: Diabetic peripheral neuropathy 
Experience sharing: Submitted on 24.8.14, it's the 20th now and still running technical checks, a bit slow, will provide further updates in the next step.
(0) 讚! | 筑阳蕙兰

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-30 18:17:21 評論於
You can contact the editorial department, this time is indeed a bit long.
(0) 讚! | Adelaide Lawson

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/12)

開始撰寫 [MOLECULAR NEUROBIOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*